Role of Brodalumab in the Modulation of Gut Microbiome in Psoriatic Patients

NCT04680624 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
15
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Association pour la Recherche Clinique et Immunologique